3 completed, 3 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Terminated 2, Completed 1 |
Follow Spiolto Respimat: new trials by email Literature Review of Spiolto Respimat trials Research Report on Spiolto Respimat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ANTES B+ Clinical Trial Trelegy Ellipta 100/62.5/25Mcg Inh 30D, Brimica, Duaklir - Chronic Obstructive Pulmonary Disease | Phase 4 | Terminated | Fundacio Privada Mon Clinic Barcelona | 48 | 2024-02-29 | 2025-08-14 |
| Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data Tiotropium+Olodaterol, Spiolto Respimat, Long-acting muscarinic antagonists (LAMAs) - Pulmonary Disease, Chronic Obstructive | Completed | Boehringer Ingelheim | 19467 | 2022-09-30 | 2024-12-04 | |
| Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease Bronchodilator Agents - Pulmonary Disease, Chronic Obstructive | Phase 4 | Terminated | Università degli Studi di Ferrara | 843 | 2018-11-11 | 2022-12-28 |
| INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and Olodaterol Tiotropium & olodaterol, fluticasone furoate & vilanterol - Chronic Obstructive Pulmonary Disease | Phase 4 | Completed | University of Dundee | 80 | 2017-06-01 | 2020-07-20 |
| Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO) Spiolto Respimat - Pulmonary Disease, Chronic Obstructive | Terminated | Boehringer Ingelheim | 132 | 2016-08-26 | 2019-04-16 | |
| Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice Spiolto Respimat - Pulmonary Disease, Chronic Obstructive | Completed | Boehringer Ingelheim | 1737 | 2016-01-13 | 2018-10-15 |
Pulmonary Disease, Chronic Obstructive (6)
Boehringer Ingelheim (3) · Fundacio Privada Mon Clinic Barcelona (1) · University of Dundee (1) · Università degli Studi di Ferrara (1)
Belgium (1) · China (1) · Denmark (1) · Germany (1) · Italy (1) · Luxembourg (1) · Netherlands (1) · Portugal (1) · Spain (1) · Sweden (1) · United Kingdom (1)
James Chalmers, MBChB, MRCP (1)
2016 (1), 2023 (1)